Sensus Healthcare Inc (STU:5TX)

Q1 2025 Sensus Healthcare Inc Earnings Call Transcript

May 15, 2025 / 08:30 PM GMT

Release Date Price: €4.1 (-3.76%)

Transcript 10-Q8-K

Key Points

Positve

Sensus Healthcare Inc (SRTS) expanded awareness of its fair deal agreement program, enhancing brand visibility through major industry events.
The company shipped 21 SRT systems in Q1, bringing the total installed base to over 880 systems, with expectations to surpass 900 systems by the end of Q2.
Sensus Healthcare Inc (SRTS) anticipates returning to profitability in each of the next three quarters and for the full year.
The fair deal agreement program showed a 65% increase in patient treatments from Q4 to Q1, indicating strong potential for long-term profitability.
The company is progressing with its international strategy and product innovation pipeline, including enhancements to its transdermal infusion system (TDI).

Negative

Revenue for Q1 2025 was $8.3 million, down from $10.7 million in Q1 2024, primarily due to lower unit sales to the largest customer.
Operating expenses were significantly higher compared to the previous year, driven by strategic growth initiatives.
Sensus Healthcare Inc (SRTS) reported a net loss of $2.6 million for Q1 2025, compared to a net income of $2.3 million in the prior year quarter.
General and administrative expenses rose to $2.2 million from $1.6 million a year ago due to professional fees and compensation.
The company anticipates significant revenue contributions from the fair deal agreements starting in the second half of 2025, indicating a delay in immediate revenue impact.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SRTS.OQ - Sensus Healthcare Inc
Q1 2025 Sensus Healthcare Inc Earnings Call
May 15, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Census Healthcare first quarter 2025 financial results conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad to withdraw your question, please press star, then 2. Please note this event is being recorded. I would now like to turn the conference over to Turth Patel with Alliance Advisors. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.